https://www.selleckchem.com/pr....oducts/syrosingopine
3%; 95% CI 0.1%-1.1%) infants with 30-day follow-up had adverse events, including lymphadenitis (1) and culture-negative sepsis (1). Diagnostic testing for IBI varied across sites and by age; overall, 278 (17.0%) had blood cultures, and 102 (6.2%) had CSF cultures obtained. Compared with infants 0 to 28 days old, older infants were less likely to have blood cultures ( .001) or CSF cultures ( .001) obtained. Afebrile infants with clinician-diagnosed AOM have a low prevalence of IBIs and adverse events; therefore,
إعجاب
علق
شارك
